Advertisement |
|
Watch Webinar: The Role of Adenine Methylation in Determining the Pathogenicity of a Bacteria Learn how Eric Schadt, Mt. Sinai Medical Center, identified a deadly strain of E. coli and further characterized it using the base modification detection capabilities of the PacBio® RS. Dr. Schadt shares how SMRT® technology improved the genome assembly of the bacteria in order to properly classify it and then explores the methylome and its effects on the biochemical function of the outbreak strain. | | |
|
|
TABLE OF CONTENTS |
June 2012 Volume 30, Issue 6 |
| | |
| In This Issue Editorial News Bioentrepreneur Opinion and Comment Features News and Views Research Highlights Computational Biology Research Errata Corrigenda Careers and Recruitment
| | Advertisement | | | | Genome editing with pico precision and mega flexibility GeneArt® Precision TALs provide DNA-binding proteins for more precise targeting and genome editing. Target any locus in the genome. Choose your effectors and Gateway® technology–compatible vector. Your clone will typically be delivered within 3 weeks after submitting your order. Learn more | |
|
|
|
|
|
|
Advertisement |
|
|
|
|
Advertisement |
|
Relay Technology Management
Real time business intelligence and data visualization for the Life Science Industry Trend monitoring and comparative asset analysis
Click here for more information or to arrange a trial. | |
|
|
In This Issue | Top |
|
|
|
In this issue ppvii - viii doi:10.1038/nbt.2274
|
|
Editorial | Top |
|
|
|
Discontent with consent p469 doi:10.1038/nbt.2270 A new type of patient consent promises to galvanize how personal genomic and medical data are shared in open research environments.
|
|
News | Top |
|
|
|
Proof of concept for next-generation nanoparticle drugs in humans pp471 - 473 Cormac Sheridan doi:10.1038/nbt0612-471
|
|
|
|
First plant-made biologic approved p472 Jeffrey L Fox doi:10.1038/nbt0612-472
|
|
|
|
Pharma bankrolls academic institutes p474 Gunjan Sinha doi:10.1038/nbt0612-474a
|
|
|
|
Agency defies advice and rejects gene therapy for third time p474 Nuala Moran doi:10.1038/nbt0612-474b
|
|
|
|
Anti-IL-17 mAbs herald new options in psoriasis pp475 - 477 Ken Garber doi:10.1038/nbt0612-475
|
|
|
|
Claims expose fatal events p476 Malorye Allison doi:10.1038/nbt0612-476
|
|
|
|
Around the world in a month p477 doi:10.1038/nbt0612-477
|
|
|
|
JOBS Act to jumpstart small business p478 Jeffrey L Fox doi:10.1038/nbt0612-478a
|
|
|
|
Wellcome partners to make drugs for India p478 Killugudi Jayaraman doi:10.1038/nbt0612-478b
|
|
|
|
Shire drops 'emergency' Fabry's disease drug p478 Jeffrey L Fox doi:10.1038/nbt0612-478c
|
|
|
|
Gintuit cell therapy approval signals shift at US regulator p479 Charles Schmidt doi:10.1038/nbt0612-479
|
|
|
|
Newsmaker |
|
|
|
Cathay Industrial Biotech p480 Emily Waltz doi:10.1038/nbt0612-480 This Chinese biotech exemplifies how companies in emerging markets can thrive in low-margin industrial applications.
|
|
|
|
Obituary |
|
|
|
George Rathmann 1927-2012 p481 doi:10.1038/nbt0612-481 Not for nothing was the founding father of Amgen known as the Golden Throat.
|
|
|
|
News Feature |
|
|
|
The gatekeepers of effectiveness pp482 - 484 Mark Ratner doi:10.1038/nbt.2265 Comparative effectiveness, especially in its new guise of patient-centered outcomes research, is all the rage in US policy circles. Will it really make a difference to healthcare? Mark Ratner reports.
|
|
Bioentrepreneur | Top |
|
|
|
Reaching across the table pp485 - 487 Pamela Cox and Benjamin Dibling doi:10.1038/nbt.2202
|
|
Opinion and Comment | Top |
|
|
|
Correspondence |
|
|
|
Should preclinical studies be registered? pp488 - 489 Jonathan Kimmelman and James A Anderson doi:10.1038/nbt.2261
|
|
|
|
The need for innovation in biomanufacturing pp489 - 492 Uwe Gottschalk, Kurt Brorson and Abhinav A Shukla doi:10.1038/nbt.2263
|
|
|
|
European agricultural policy goes down the tubers pp492 - 493 Christina Dixelius, Torbjorn Fagerstrom and J F Sundstrom doi:10.1038/nbt.2255
|
|
|
|
Transgenic insect resistance traits increase corn yield and yield stability pp493 - 496 Michael D Edgerton, Jon Fridgen, John R Anderson Jr, Jenne Ahlgrim, Monty Criswell, Prabhakar Dhungana, Tom Gocken, Zheng Li, Sadayappan Mariappan, Clinton D Pilcher, Arnold Rosielle and Steven B Stark doi:10.1038/nbt.2259
|
|
|
|
Commentary |
|
|
|
Geron's quixotic fate p497 Christopher Scott and Brady Huggett doi:10.1038/nbt.2253 Why did Geron—corporate standard bearer for regenerative medicine—fail, whereas technology pioneers in other areas persist?
|
|
Features | Top |
|
|
|
Patents |
|
|
|
Biomarker patents for diagnostics: problem or solution? pp498 - 500 Michael M Hopkins and Stuart Hogarth doi:10.1038/nbt.2257 Patents on genes and other types of biomarkers have caused much controversy, but their importance to diagnostic innovation is in danger of being overlooked.
|
|
|
|
Recent patent applications in pluripotent stem cells p501 doi:10.1038/nbt.2272
|
|
News and Views | Top |
|
|
|
|
|
Research Highlights | Top |
|
|
|
Anti-stress therapy for muscular dystrophy | Safer lentiviral vectors | Protein characterization via aptamers | Rare-cell signature predicts heart attack | Mapping the newest epigenetic mark
|
Computational Biology | Top |
|
|
|
News Feature |
|
|
|
My data are your data pp509 - 511 Vivien Marx doi:10.1038/nbt.2243 Encouraging more broad and inclusive data sharing in today's world will involve concerted community efforts to overcome technical barriers and human foibles. Vivien Marx investigates.
|
|
Research | Top |
|
|
|
Perspective |
|
|
|
Unlocking the potential of metagenomics through replicated experimental design pp513 - 520 Rob Knight, Janet Jansson, Dawn Field, Noah Fierer, Narayan Desai, Jed A Fuhrman, Phil Hugenholtz, Daniel van der Lelie, Folker Meyer, Rick Stevens, Mark J Bailey, Jeffrey I Gordon, George A Kowalchuk and Jack A Gilbert doi:10.1038/nbt.2235
|
|
|
|
Articles |
|
|
|
Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters pp521 - 530 Eilon Sharon, Yael Kalma, Ayala Sharp, Tali Raveh-Sadka, Michal Levo, Danny Zeevi, Leeat Keren, Zohar Yakhini, Adina Weinberger and Eran Segal doi:10.1038/nbt.2205 Analyzing the effects of multiple promoter motifs on gene expression can be a laborious process. Sharon et al. present a high-throughput method to measure the expression of thousands of designed yeast promoters in a single experiment and use it to reveal new features of transcriptional regulation.
See also: News and Views by Haberle & Lenhard
|
|
|
|
Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells pp531 - 542 Micha Drukker, Chad Tang, Reza Ardehali, Yuval Rinkevich, Jun Seita, Andrew S Lee, Adriane R Mosley, Irving L Weissman and Yoav Soen doi:10.1038/nbt.2239 Drukker and colleagues differentiated human embryonic stem (ES) cells for 3 days and screened the cells for labeling by >400 antibodies. They identified cell-surface markers expressed on four classes of early progenitor cell.
|
|
|
|
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing pp543 - 548 Timothy A Whitehead, Aaron Chevalier, Yifan Song, Cyrille Dreyfus, Sarel J Fleishman, Cecilia De Mattos, Chris A Myers, Hetunandan Kamisetty, Patrick Blair, Ian A Wilson and David Baker doi:10.1038/nbt.2214 To increase the affinity of designed protein inhibitors for influenza hemagglutinin, Whitehead et al. use yeast display and deep sequencing to measure the effects on binding of ~1,000 amino-acid substitutions. Rare beneficial mutations are then combined and screened, yielding inhibitors with ~25-fold lower dissociation constants.
See also: News and Views by Wodak
|
|
|
|
Genome sequence of foxtail millet (Setaria italica) provides insights into grass evolution and biofuel potential pp549 - 554 Gengyun Zhang, Xin Liu, Zhiwu Quan, Shifeng Cheng, Xun Xu, Shengkai Pan, Min Xie, Peng Zeng, Zhen Yue, Wenliang Wang, Ye Tao, Chao Bian, Changlei Han, Qiuju Xia, Xiaohua Peng, Rui Cao, Xinhua Yang, Dongliang Zhan, Jingchu Hu, Yinxin Zhang, Henan Li, Hua Li, Ning Li, Junyi Wang, Chanchan Wang, Renyi Wang, Tao Guo, Yanjie Cai, Chengzhang Liu, Haitao Xiang, Qiuxiang Shi, Ping Huang, Qingchun Chen, Yingrui Li, Jun Wang, Zhihai Zhao and Jian Wang doi:10.1038/nbt.2195 Completion of genome sequences for the diploid Setaria italica reveals features of C4 photosynthesis that could enable improvement of the polyploid biofuel crop switchgrass (Panicum virgatum). The genetic basis of biotechnologically relevant traits, including drought tolerance, photosynthetic efficiency and flowering control, is also highlighted.
|
|
|
|
Reference genome sequence of the model plant Setaria pp555 - 561 Jeffrey L Bennetzen, Jeremy Schmutz, Hao Wang, Ryan Percifield, Jennifer Hawkins, Ana C Pontaroli, Matt Estep, Liang Feng, Justin N Vaughn, Jane Grimwood, Jerry Jenkins, Kerrie Barry, Erika Lindquist, Uffe Hellsten, Shweta Deshpande, Xuewen Wang, Xiaomei Wu, Therese Mitros, Jimmy Triplett, Xiaohan Yang, Chu-Yu Ye, Margarita Mauro-Herrera, Lin Wang, Pinghua Li, Manoj Sharma, Rita Sharma, Pamela C Ronald, Olivier Panaud, Elizabeth A Kellogg, Thomas P Brutnell, Andrew N Doust, Gerald A Tuskan, Daniel Rokhsar and Katrien M Devos doi:10.1038/nbt.2196 Completion of genome sequences for the diploid Setaria italica reveals features of C4 photosynthesis that could enable improvement of the polyploid biofuel crop switchgrass (Panicum virgatum). The genetic basis of biotechnologically relevant traits, including drought tolerance, photosynthetic efficiency and flowering control, is also highlighted.
|
|
Errata | Top |
|
|
|
Reinventing clinical trials p562 Malorye Allison doi:10.1038/nbt0612-562a
|
|
|
|
Parallel genome universes p562 Tom Misteli doi:10.1038/nbt0612-562b
|
|
|
|
BASF moves GM crop research to US p562 Lucas Laursen doi:10.1038/nbt0612-562c
|
|
|
|
In Their Words p562 doi:10.1038/nbt0612-562d
|
|
Corrigenda | Top |
|
|
|
Performance comparison of whole-genome sequencing platforms p562 Hugo Y K Lam, Michael J Clark, Rui Chen, Rong Chen, Georges Natsoulis, Maeve O'Huallachain, Frederick E Dewey, Lukas Habegger, Euan A Ashley, Mark B Gerstein, Atul J Butte, Hanlee P Ji and Michael Snyder doi:10.1038/nbt0612-562e
|
|
|
|
Performance comparison of benchtop high-throughput sequencing platforms p562 Nicholas J Loman, Raju V Misra, Timothy J Dallman, Chrystala Constantinidou, Saheer E Gharbia, John Wain and Mark J Pallen doi:10.1038/nbt0612-562f
|
|
Careers and Recruitment | Top |
|
|
|
The importance of matching talented leadership with the growth stage of your life-sciences company pp563 - 565 J Michael Honeysett and Richard Metheny doi:10.1038/nbt.2267 In the life sciences' rapidly changing business climate, it is imperative that companies find innovative, effective and enlightened leadership.
|
|
|
|
People |
|
|
|
People p566 doi:10.1038/nbt.2271
|
|
Top |
|
|
Advertisement |
|
|
|
|
| | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | |
|
|
No comments:
Post a Comment